Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2002-07-29
2011-10-04
Anderson, James (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S075000
Reexamination Certificate
active
08030348
ABSTRACT:
A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.
REFERENCES:
patent: 2003/0083238 (2003-05-01), Toda et al.
patent: 0 609 078 (1994-08-01), None
patent: WO 92 21335 (1992-12-01), None
patent: WO 97 39759 (1997-10-01), None
patent: WO 00 23546 (2000-04-01), None
ACS Chemical Registry, “4H-1-Benzopyran-4-one, 2-(3,4-dihydroxypheny1)-6,8-di-β-D-glucopyranosyl-5,7-dihydroxy-, ”, Nov. 16, 1984, 1 page.
Aureli , M. et al. Aging brain: effect of acetyl L-carnitine treatment on rat brain energy and phospholipid metabolism. A study by31P and1H NMR spectroscopy.Brain Research. 1990; 526(1): 108-112.
Barak, Y. et al. Inositol treatment of Alzheimer's disease : a double blind, cross-over placebo controlled trial.Prog. Neuropsychopharmacol. Biol. Psychiatry1996; 20: 729-735.
Bast, A. et al. Interlay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation.Biochem. Biophys. Acta. 1988; 963: 558-561.
Bell, M.V. et al. Molecular Species Composition of the Major Diacyl Glycerophospholipids from Muscle, Liver, Retina and Brain of Cod (Gadus morhua). Lipids 1991: 26(8): 563-73.
Benjamin, J. et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorders.Am. J. Psychiatry1995; 15: 1084-1086.
Birchall, J. et al. Aluminum, chemical physiology, and Alzheimer's disease.Lancet1988; 29:1008-1010.
Caprioli, A. et al. Age-dependent deficits in radial maze performance in the rats: effect of chronic treatment with acetyl L-carnitine.Prog. In Neuropsychopharmacol. Biol. Psychiatr. 1990; 14(3): 3 59-369.
Cheng, D. et al. A novel promising acetylcholinesterase inhibitor.Neuroreport1996; 8: 97-101.
Devasagayam, T.P. et al., Prevention of Singlet Oxygen-Induced DNA Damage by Lipoate.Chemical Biological Interactions1993; 86 : 79-92.
Ghirardi, O. et al. Effects of acetyl L-carnitine chronic treatment on discrimination models in aged rats.Pysiol. Behav. 1988; 44(6): 769-773.
Gill, D.L. et al. Calcium signalling mechanisms in endoplasmic reticulum activated by inositol 1, 4, 5 triphosphate and GTP.Cell Calcium1989; 10: 363-374.
Henderson, R.J. et al. Lipid Composition fo the Pineal Organ from Rainbow Trout (Oncorhynchus mykiss).Lipids1994; 29(5): 311-17.
Hosokawa, M. et al., Conversion to Docosahexaenoic Acid-Containing Phosphatidylserine from Squid Skin Lecithin by Phospholipase D-Mediated Transphosphataidylation.Journal of Agricultural and Food Chemistry20000; 48(10): 4550-54.
Imperato, A. et al. L-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats.Neuroscience Letters. 1989: 107(1-3): 251-255.
Kagan, V.E. et al. Dihydrolipoic acid: A universal antioxidant both in the membrane and in the aqueous phase.Biochem. Pharmacol. 1992; 44: 1637-1649.
Kawakami, Y. et al. The rationale for E2020 as a potent acetylcholinesterase inhibitor.Bioorg. Med. Chem. 1996; 4: 1429-1446.
Kitamura, H. et al. Inhibition of myo-inositol transport causes acute renal failure with selective medullary injury in the rat.Kidney Int. 1998; 53: 146-153.
Knopman, D. et al. Long term tacrine (Cognex) treatment: effects on nursing home placement and mortality, tacrine study group.Neurology1996; 47: 166-167.
Levine, J. et al. Double-blind, controlled trial of inositol treatment of depression.Am. J. Psychiatry1995; 152: 792-794 (Abstract Only).
Levine, J. et al. Inositol treatment raises CSF inositol levels.Brain Research1993; 627 : 168-169.
Levine, J. Controlled trials of inositol in psychiatry.Eur. Neuropsychopharmacol. 1997; 7: 147-155.
Colodny, L. et al.Altern. Med. Rev. 1998; 3(6): 432-447.
Mohr, E. et al. Treatment of Alzheimer's disease with sabeluzole : functional and structural correlates.Clin. Neuropharmacol. 1997; 20: 338-345 (Abstract Only).
Paradies, G. et al. Carnitine-acylcarnitine translocase activity in cardiac mitochondria from aged rats: the effect of acetyl-L-carnitine.Mech. of Aging and Develop. 1995; 84(2): 103-112.
Parthasarathy, L. et al. Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase.Life Sci. 1994; 54: 1127-1142.
Rogers, S. et al. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The donepezil study group.Dementia1996; 7: 293-303 (Abstract Only).
Schneider, L. et al. Potential role for estrogen replacement in the treatment of Alzheimer's dementia.Am. J. Med. 1997; 103: 46S-50S.
Seidman, M. Polyunsaturated Phosphatidylcholine in NT Factor™ Improves Mitochondrial Function, Auditory Sensitivity and May Slow Some Aspects of the Aging Processes.Anti-Aging Medical News, Winter 2001.
Suzuki, Y.J. et al. Aipha-lipoic acid is a potent inhibitor of NFKb activation in human Tcells.Biochem. Biophys. Res. Commun. 1992; 189: 1709-1715 (Abstract Only).
Van Dyck, C. et al. The acetylcholine releaser linopiridine increases pariental regional cerebral blood flow in Alzheimer's disease.Psychopharmacology1997; 132: 217-226.
Wiegand, R. et al. Phospholipid Molecular Species of Frog Rod Outer Segment Membranes.Exp. Eye Res. 1983; 37(2): 159-73.
Anderson James
Neptune Technologies & Bioressources Inc.
Polansky Gregg
LandOfFree
Natural marine source phospholipids comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Natural marine source phospholipids comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Natural marine source phospholipids comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4265283